Medical Properties Trust, Inc. (MPT) Stock Forecast
Data as of Oct 31, 2026Real Estate · Current price $2.27 (-7.17%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 11, 2025 | Nate Crossett | BNP Paribas | $9.00 | +297.4% |
| Sep 13, 2024 | Michael Lewis | Truist Financial | $6.00 | +164.9% |
| Sep 13, 2024 | David Toti | Colliers Securities | $6.50 | +187.0% |
| Sep 12, 2024 | Vikram Malhotra | Mizuho Securities | $7.00 | +209.1% |
| Aug 2, 2024 | Dori Kesten | Wells Fargo | $7.50 | +231.1% |
| Aug 2, 2024 | Michael Lewis | Truist Financial | $8.00 | +253.2% |
| Jul 1, 2024 | Nate Crossett | BNP Paribas | $4.00 | +76.6% |
| May 29, 2024 | Michael Lewis | Truist Financial | $5.00 | +120.8% |
| May 13, 2024 | Michael Carroll | RBC Capital | $5.00 | +120.8% |
| Apr 17, 2024 | Omotayo Okusanya | Deutsche Bank | $5.00 | +120.8% |
| Apr 8, 2024 | Michael Lewis | Truist Financial | $4.50 | +98.7% |
| Aug 14, 2023 | Michael Carroll | RBC Capital | $10.00 | +341.5% |
| Apr 22, 2022 | Jonathan Petersen | Jefferies | $20.00 | +783.0% |
| Nov 23, 2021 | Steven Valiquette | Barclays | $27.00 | +1092.1% |
| Oct 29, 2021 | Jonathan Hughes | Raymond James | $26.00 | +1047.9% |
| May 4, 2021 | Jordan Sadler | KeyBanc | $24.00 | +959.6% |
Top Analysts Covering MPT
MPT vs Sector & Market
| Metric | MPT | Real Estate Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.67 | 2.60 | 2.41 |
| Analyst Count | 3 | 9 | 19 |
| Target Upside | +28.0% | +370.8% | +21.5% |
| P/E Ratio | -11.21 | 25.72 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $258M | $259M | $261M | 1 |
| 2027-03-31 | $263M | $264M | $266M | 1 |
| 2027-06-30 | $263M | $265M | $266M | 1 |
| 2027-09-30 | $263M | $265M | $266M | 1 |
| 2027-12-31 | $263M | $265M | $266M | 1 |
| 2028-12-31 | $1.05B | $1.07B | $1.11B | 1 |
| 2029-12-31 | $1.09B | $1.11B | $1.14B | 1 |
| 2030-12-31 | $1.12B | $1.14B | $1.18B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.03 | $0.03 | $0.03 | 1 |
| 2027-03-31 | $0.03 | $0.04 | $0.04 | 1 |
| 2027-06-30 | $0.03 | $0.04 | $0.04 | 1 |
| 2027-09-30 | $0.03 | $0.04 | $0.04 | 1 |
| 2027-12-31 | $0.03 | $0.03 | $0.03 | 1 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for MPT?
The consensus among 3 analysts covering Medical Properties Trust, Inc. (MPT) is Sell with an average price target of $3.80.
What is the highest price target for MPT?
The highest price target for MPT is $27.00, set by Steven Valiquette at Barclays on 2021-11-23.
What is the lowest price target for MPT?
The lowest price target for MPT is $4.00, set by Nate Crossett at BNP Paribas on 2024-07-01.
How many analysts cover MPT?
3 analysts have issued ratings for Medical Properties Trust, Inc. in the past 12 months.
Is MPT a buy or sell right now?
Based on 3 analyst ratings, MPT has a consensus rating of Sell (3.67/5) with a +28.0% upside to the consensus target of $3.80.
What are the earnings estimates for MPT?
Analysts estimate MPT will report EPS of $0.03 for the period ending 2026-12-31, with revenue estimated at $259M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.